Global Hospital Injectable Drugs Supply, Demand and Key Producers, 2026-2032
Description
The global Hospital Injectable Drugs market size is expected to reach $ 65370 million by 2032, rising at a market growth of 4.7% CAGR during the forecast period (2026-2032).
Injectables refer to drug delivery system which acts as an alternative to oral drugs. As injectables are rapidly inserted into the human body using a syringe, they bypass the first-pass metabolism. In tablet form, some of the drugs become ineffective as they get dismantled in the stomach owing to the digestive enzymes. Generic injectables are pharmaceutical drugs that are bio-equivalent of a branded injectable in terms of dosage, strength, performance, intended use, side-effects and route of administration.
In 2019, North America held the main share in global hospital injectable drugs market,with the propotion of 35%,Europe followed loosely ,at the propotion of 33%.
Hospira (Pfizer Inc.) occupied the biggest global hospital injectable drugs market share(13%), Fresenius Kabi followed closely at the propotion of 13%, Baxter and Sichuan Kelun Pharmaceutical also played a virtal role in the market.
This report studies the global Hospital Injectable Drugs demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Hospital Injectable Drugs, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Hospital Injectable Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Hospital Injectable Drugs total market, 2021-2032, (USD Million)
Global Hospital Injectable Drugs total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Hospital Injectable Drugs total market, key domestic companies, and share, (USD Million)
Global Hospital Injectable Drugs revenue by player, revenue and market share 2021-2026, (USD Million)
Global Hospital Injectable Drugs total market by Type, CAGR, 2021-2032, (USD Million)
Global Hospital Injectable Drugs total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Hospital Injectable Drugs market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hospira (Pfizer Inc.), Baxter, Fresenius Kabi, Sandoz (Novartis), Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories Ltd, Grifols, Nichi-Iko Group (Sagent), Teva Pharmaceutical, Otsuka, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Hospital Injectable Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Hospital Injectable Drugs Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Hospital Injectable Drugs Market, Segmentation by Type:
Generic Sterile Injectables
Sterile Intravenous (IV) Solutions
Global Hospital Injectable Drugs Market, Segmentation by Application:
Oncology
Anesthesia
Anti-Infectives
Parenteral Nutrition
Cardiovascular Diseases
Companies Profiled:
Hospira (Pfizer Inc.)
Baxter
Fresenius Kabi
Sandoz (Novartis)
Hikma Pharmaceuticals PLC
Dr. Reddy’s Laboratories Ltd
Grifols
Nichi-Iko Group (Sagent)
Teva Pharmaceutical
Otsuka
B.Braun
JW Life Science
Auromedics
Sanofi
Gland Pharma
Endo International PLC
Sichuan Kelun Pharmaceutical
Cisen Pharmaceutical
Shijiazhuang No. 4 Pharmaceutical
Shandong Hualu Pharmaceutical
CR Double-Crane
Key Questions Answered
1. How big is the global Hospital Injectable Drugs market?
2. What is the demand of the global Hospital Injectable Drugs market?
3. What is the year over year growth of the global Hospital Injectable Drugs market?
4. What is the total value of the global Hospital Injectable Drugs market?
5. Who are the Major Players in the global Hospital Injectable Drugs market?
6. What are the growth factors driving the market demand?
Injectables refer to drug delivery system which acts as an alternative to oral drugs. As injectables are rapidly inserted into the human body using a syringe, they bypass the first-pass metabolism. In tablet form, some of the drugs become ineffective as they get dismantled in the stomach owing to the digestive enzymes. Generic injectables are pharmaceutical drugs that are bio-equivalent of a branded injectable in terms of dosage, strength, performance, intended use, side-effects and route of administration.
In 2019, North America held the main share in global hospital injectable drugs market,with the propotion of 35%,Europe followed loosely ,at the propotion of 33%.
Hospira (Pfizer Inc.) occupied the biggest global hospital injectable drugs market share(13%), Fresenius Kabi followed closely at the propotion of 13%, Baxter and Sichuan Kelun Pharmaceutical also played a virtal role in the market.
This report studies the global Hospital Injectable Drugs demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Hospital Injectable Drugs, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Hospital Injectable Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Hospital Injectable Drugs total market, 2021-2032, (USD Million)
Global Hospital Injectable Drugs total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Hospital Injectable Drugs total market, key domestic companies, and share, (USD Million)
Global Hospital Injectable Drugs revenue by player, revenue and market share 2021-2026, (USD Million)
Global Hospital Injectable Drugs total market by Type, CAGR, 2021-2032, (USD Million)
Global Hospital Injectable Drugs total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Hospital Injectable Drugs market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hospira (Pfizer Inc.), Baxter, Fresenius Kabi, Sandoz (Novartis), Hikma Pharmaceuticals PLC, Dr. Reddy’s Laboratories Ltd, Grifols, Nichi-Iko Group (Sagent), Teva Pharmaceutical, Otsuka, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Hospital Injectable Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Hospital Injectable Drugs Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Hospital Injectable Drugs Market, Segmentation by Type:
Generic Sterile Injectables
Sterile Intravenous (IV) Solutions
Global Hospital Injectable Drugs Market, Segmentation by Application:
Oncology
Anesthesia
Anti-Infectives
Parenteral Nutrition
Cardiovascular Diseases
Companies Profiled:
Hospira (Pfizer Inc.)
Baxter
Fresenius Kabi
Sandoz (Novartis)
Hikma Pharmaceuticals PLC
Dr. Reddy’s Laboratories Ltd
Grifols
Nichi-Iko Group (Sagent)
Teva Pharmaceutical
Otsuka
B.Braun
JW Life Science
Auromedics
Sanofi
Gland Pharma
Endo International PLC
Sichuan Kelun Pharmaceutical
Cisen Pharmaceutical
Shijiazhuang No. 4 Pharmaceutical
Shandong Hualu Pharmaceutical
CR Double-Crane
Key Questions Answered
1. How big is the global Hospital Injectable Drugs market?
2. What is the demand of the global Hospital Injectable Drugs market?
3. What is the year over year growth of the global Hospital Injectable Drugs market?
4. What is the total value of the global Hospital Injectable Drugs market?
5. Who are the Major Players in the global Hospital Injectable Drugs market?
6. What are the growth factors driving the market demand?
Table of Contents
164 Pages
- 1 Supply Summary
- 2 Demand Summary
- 3 World Hospital Injectable Drugs Companies Competitive Analysis
- 4 United States VS China VS Rest of World (by Headquarter Location)
- 5 Market Analysis by Type
- 6 Market Analysis by Application
- 7 Company Profiles
- 8 Industry Chain Analysis
- 9 Research Findings and Conclusion
- 10 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
